Bryan M. Davis's research while affiliated with University of Colorado Colorado Springs and other places
What is this page?
This page lists the scientific contributions of an author, who either does not have a ResearchGate profile, or has not yet added these contributions to their profile.
It was automatically created by ResearchGate to create a record of this author's body of work. We create such pages to advance our goal of creating and maintaining the most comprehensive scientific repository possible. In doing so, we process publicly available (personal) data relating to the author as a member of the scientific community.
If you're a ResearchGate member, you can follow this page to keep up with this author's work.
If you are this author, and you don't want us to display this page anymore, please let us know.
It was automatically created by ResearchGate to create a record of this author's body of work. We create such pages to advance our goal of creating and maintaining the most comprehensive scientific repository possible. In doing so, we process publicly available (personal) data relating to the author as a member of the scientific community.
If you're a ResearchGate member, you can follow this page to keep up with this author's work.
If you are this author, and you don't want us to display this page anymore, please let us know.
Publications (2)
Background
Temperature-controlled radiofrequency neurolysis of the posterior nasal nerve has been shown to reduce the symptom burden of patients with chronic rhinitis.
Objectives
To evaluate the long-term safety and effectiveness of temperature-controlled radiofrequency neurolysis of the posterior nasal nerve for the treatment of chronic rhinitis....
Citations
... In this randomised controlled trial (RCT), the efficacy of the VivAer® System (Aerin Medical, Mountain View, CA, USA) was superior to a sham procedure control in treating patients with NAO and NVD at 3 months posttreatment (3) . In this report, the long-term follow-up of the patients receiving active treatment in this RCT serves to complement effectiveness study data (4,5) and feasibility/pivotal study data (6)(7)(8)(9) . Long-term data is important for patients and providers when considering NAO treatment options, to compare the minimally-invasive approach against surgical outcomes, to evaluate the effect of symptom improvements on concomitant medication and nasal dilator usage, to support cost-effectiveness studies, and to confirm the safety profile of the device and procedure over time. ...
![[object Object]](https://i1.rgstatic.net/ii/profile.image/1165399735451648-1654864357675_Q64/Ofer-Jacobowitz.jpg)
... Single contact point radiofrequency and cryoablative devices, as employed in our analysis, have been established as safe and efficacious, and we highlight here how a simple modification of the existing technique has potential to improve outcomes. 16,17 In our experience, TCRF and cryoablation generally have favorable safety profiles, and the introduction of the modified technique has not resulted in increased adverse events. In a study of a national adverse events reporting database, for the Clarifix cryoablation device, epistaxis was found to be the most common reported adverse event (9/12, 75%). ...
